Radiation-enhanced expression of major histocompatibility complex (mhc) class I antigens in B16 melanoma cells
β Scribed by Stephen H. Hauser; Lido Calorini; David E. Wazer; Carmia Borek; Sebastiano Gattoni-Celli
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 106 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background and Objective Photodynamic therapy (PDT) is FDAβapproved antiβcancer modality for elimination of early disease and palliation in advanced disease. PDT efficacy depends in part on elicitation of a tumorβspecific immune response that is dependent on cytotoxic T lymphocytes
Besides their "classical" antigenic peptide-presenting activity, major histocompatibility complex (MHC) class II antigens can activate different cellular functions in immune and nonimmune cells. However, this "nonclassical" role and its functional consequences are still substantially overlooked. In
The expression of the major histocompatibility complex Class I antigens (Class I) was investigated in the nervous system of twitcher (C57BL/6J-twi), a murine model of Krabbe disease in humans. Class I mRNA expression was low in wild type and in twitcher mice prior to the onset of demyelination. Howe
Mechanisms of major histocompatibility complex (MHC) class I gene regulation in cells of the CNS have been studied in vitro. Astrocytes in primary cultures, but neither oligodendrocytes nor neurons, constitutively expressed cell surface MHC class I molecules. Interferon-gamma (IFN-.I) treatment led